UK’s Equine Analytical Chemistry Lab acquired by Eagle Diagnostics
A new chapter in equine science and research is underway as the University of Kentucky announces the transition of its Equine Analytical Chemistry Laboratory to new ownership under Eagle Diagnostics. Now operating as Equine Integrity & Anti-doping Sciences (EQIAS) Labs, the facility will continue to serve as a leader in antidoping testing for the equine and competition animal industries while expanding opportunities for research and innovation.
EQIAS Labs utilizes state-of-the-art analytical equipment to detect performance-enhancing drugs in horses and other animal species to ensure fairness, integrity and animal welfare. The laboratory also performs routine analytical tests, such as an equine prepurchase drug screen, to serve the equine industry. EQIAS will maintain a collaborative partnership with the university to perform research studies to advance analytical testing capabilities, detect new and emerging threats, and support the equine industry’s initiative of ensuring equine safety and integrity.
Travis Mays, Ph.D., has been appointed as the new director of EQIAS Labs. Mays spent more than 20 years at the Texas A&M Veterinary Medical Diagnostic Laboratory overseeing daily operations of the drug testing and toxicology sections. His extensive background includes antidoping testing in racing and exhibition animals, veterinary toxicology, pharmacology and analytical chemistry. His experience and expertise will ensure the laboratory maintains its reputation for high-quality testing and innovation within the equine industry.
“We are excited about this new partnership and the opportunities it brings,” said Chris West, CFO of Sports Medicine Research and Testing Laboratory, representing Eagle Diagnostics. “EQIAS Labs looks forward to continuing our strong collaboration with the University of Kentucky, fostering future research initiatives and advancements in equine science.”
Leaders from UK echoed how this transition can increase the lab’s impact through research collaborations that support its drug testing operations and open new avenues for impactful scientific discovery.
“This transition underscores our commitment to meeting the highest industry standards for equine drug testing and expanding innovation and collaboration in equine research,” said Jamie Matthews, associate dean of research at UK’s Martin-Gatton College of Agriculture, Food and Environment. “We look forward to working closely with EQIAS Labs to ensure that the regulatory needs of the equine industry continue to be served.”
UK and Eagle Diagnostics are committed to ensuring a seamless transition with minimal disruption to laboratory services and operations. Both institutions remain dedicated to advancing research that supports the equine industry’s health and integrity.
